A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia

The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

1998 • 2,668 citations

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

2001 • 877 citations

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

1995 • 874 citations

Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)

2002 • 661 citations

Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

1998 • 628 citations

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

1998 • 580 citations

Calichemicins, a novel family of antitumor antibiotics. 2. Chemistry and structure of calichemicin .gamma.1I

1987 • 516 citations

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

1996 • 474 citations

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

1999 • 458 citations

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

1996 • 423 citations

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

2002 • 345 citations

Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia

1997 • 334 citations

Randomized Comparison of DAT Versus ADE as Induction Chemotherapy in Children and Younger Adults With Acute Myeloid Leukemia. Results of the Medical Research Council's 10th AML Trial (MRC AML10)

1997 • 321 citations

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

2003 • 304 citations

Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

2001 • 278 citations

Expression of normal myeloid-associated antigens by acute leukemia cells

1986 • 227 citations

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

2002 • 224 citations

Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.

1998 • 110 citations

Clinical trials in oncology

1993 • 106 citations

Recommended Procedures for the Classification of Acute Leukaemias

1995 • 48 citations

A<scp>CUTE</scp> M<scp>YELOID</scp> L<scp>EUKEMIA</scp>: T<scp>REATMENT</scp><scp>OF</scp> A<scp>DULTS</scp> U<scp>NDER</scp> 60 Y<scp>EARS</scp>

2002 • 47 citations

Anti-CD33 Monoclonal Antibody M195 for the Therapy of Myeloid Leukemia

1993 • 20 citations

Immature and Differentiated Neoplastic Populations in Acute Lymphoid Leukemia of Childhood: Biological and Clinical Implications

1993 • 7 citations

Intensive chemotherapy in induction and consolidation for De Novo adult acute myeloid leukemia using sequential courses of high dose cytarabine, idarubicin, and etoposide: a randomized trial of the Australian leukaemia and lymphoma group (ALLG).

2001 • 3 citations